Anteris Technologies Global Revenue Growth Rates (AVR), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Anteris Technologies Global Corp   (AVR)
 

AVR's Revenue Growth by Quarter and Year

Anteris Technologies Global 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/AVR/growth
https://api.csimarket.com/api/v1/companies/AVR/fundamentals
https://api.csimarket.com/api/v1/companies/AVR/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
AVR Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 0.52
2nd Quarter June 1.01
1st Quarter March 0.49
FY 2.02





AVR Revenue third quarter 2026 Y/Y Growth Comment
Anteris Technologies Global Corp achieved in the third quarter 2026, above Company average Revenue growth of 20.7% year on year, to $ 0.52 millions.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 22 other companies have achieved higher Revenue growth. While Anteris Technologies Global Corp ' s Revenue rise of 20.7% ranks overall at the positon no. 390 in the third quarter 2026.


AVR Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 20.7 %
2nd Quarter June 62.9 %
1st Quarter March -12.5 %
FY   -

Financial Statements
Anteris Technologies Global 's third quarter 2026 Revenue $ 0.52 millions AVR's Income Statement
Anteris Technologies Global 's third quarter 2025 Revenue $ 0.43 millions Quarterly AVR's Income Statement


AVR Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -48.61 %
2nd Quarter June 106.12 %
1st Quarter March 58.06 %
FY (Year on Year)   -


Back to AVR Growth rate Comparisons >> Back to AVR Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #23
Healthcare Sector #101
Overall #390

Revenue Y/Y Growth Statistics
High Average Low
63.27 % -10.65 % -44.21 %
(Jun 30 2026)   (Dec 31 2025)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #23
Healthcare Sector #101
Overall #390
Revenue Y/Y Growth Statistics
High Average Low
63.27 % -10.65 % -44.21 %
(Jun 30 2026)   (Dec 31 2025)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Anteris Technologies Global 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
104.25 % 10.45 % -30.58 %
(Jun 30 2026)  


AVR's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Anteris Technologies Global Corp disclosed fall in Revenue from the second quarter by -48.61% to $ 0.52 millions, from $ 1.01 millions achived in the previous reporting period.

But that's not important problem, as Anteris Technologies Global 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 8 other companies have achieved higher Revenue quarter on quarter growth. While Anteris Technologies Global 's Revenue growth quarter on quarter, overall rank is 132.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #9
Healthcare Sector #43
Overall #132
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #9
Healthcare Sector #43
Overall #132
Revenue Q/Q Growth Statistics
High Average Low
104.25 % 10.45 % -30.58 %
(Jun 30 2026)  


AVR's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Anteris Technologies Global Corp disclosed fall in Revenue from the second quarter by -48.61% to $ 0.52 millions, from $ 1.01 millions achived in the previous reporting period.

But that's not important problem, as Anteris Technologies Global 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 8 other companies have achieved higher Revenue quarter on quarter growth. While Anteris Technologies Global 's Revenue growth quarter on quarter, overall rank is 132.


Anteris Technologies Global 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)		 12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending
Cumulative Revenue 12 Months Ending $ 2.33
Y / Y Revenue Growth (TTM) 9.02 %
Year on Year Revenue Growth Overall Ranking # 3452
Seqeuential Revenue Change (TTM) 4.01 %
Seq. Revenue Growth (TTM) Overall Ranking # 3180


Cumulative Revenue growth Comment
Anteris Technologies Global saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 9.02% year on year, to $ 2 millions if the fiscal year would have ended in Sep 30 2026.
Anteris Technologies Global 's trailing twelve months Revenue growth was higher than company's average -21.51% and higher than -9.56% growth in Jun 30 2026.
But from twelve months ended Jun 30 2026 rise was beneth at 4.01 % from $2.24 millions achieved in the period from Jun 30 2026 to .
Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at -21.51%.

In the Healthcare sector 468 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3268 to 3452.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 152
Healthcare Sector # 469
Overall # 3452

Revenue TTM Y/Y Growth Statistics
High Average Low
-9.56 %
 -21.51 %
-29.23 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 152
Sector # 427
S&P 500 # 3180
Cumulative Revenue growth Comment
Anteris Technologies Global saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 9.02% year on year, to $ 2 millions if the fiscal year would have ended in Sep 30 2026.
Anteris Technologies Global 's trailing twelve months Revenue growth was higher than company's average -21.51% and higher than -9.56% growth in Jun 30 2026.
But from twelve months ended Jun 30 2026 rise was beneth at 4.01 % from $2.24 millions achieved in the period from Jun 30 2026 to .
Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at -21.51%.
The momentum is even more impressive from twelve months ended Jun 30 2026 exhibited at 4.01 % increase from $2.24 millions in the period from Jun 30 2026 to .

In the Healthcare sector 468 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3268 to 3452.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 152
Healthcare Sector # 469
Overall # 3452

Revenue TTM Y/Y Growth Statistics
High Average Low
-9.56 %
-21.51 %
-29.23 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 152
Sector # 427
S&P 500 # 3180




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
AVR's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Travere Therapeutics Inc 36.22%$ 36.215 millions
Omada Health Inc 36.13%$ 36.133 millions
Guardant Health Inc 36.12%$ 36.116 millions
Natera Inc 34.08%$ 34.077 millions
Establishment Labs Holdings Inc 34.08%$ 34.075 millions
Beone Medicines Ltd 33.86%$ 33.861 millions
Ceribell Inc 33.72%$ 33.721 millions
Zomedica Corp 33.12%$ 33.123 millions
Intuitive Surgical Inc 32.71%$ 32.714 millions
Adc Therapeutics Sa32.20%$ 32.197 millions
Biomarin Pharmaceutical Inc32.02%$ 32.019 millions
The Pennant Group Inc 31.96%$ 31.965 millions
Beta Bionics Inc 30.92%$ 30.923 millions
Cadre Holdings inc 30.36%$ 30.362 millions
Krystal Biotech Inc 30.21%$ 30.206 millions
Sight Sciences Inc 29.83%$ 29.828 millions
Ge Healthcare Technologies Inc 29.41%$ 29.413 millions
Moderna Inc 29.23%$ 29.232 millions
Sonoma Pharmaceuticals Inc 28.02%$ 28.016 millions
Ani Pharmaceuticals Inc27.64%$ 27.638 millions
Geron Corporation27.45%$ 27.448 millions
Vericel Corporation26.47%$ 26.470 millions
Axogen inc 26.22%$ 26.218 millions
Cardio Diagnostics Holdings Inc 25.74%$ 25.744 millions
Edap Tms Sa25.55%$ 25.549 millions
Lifestance Health Group Inc 25.30%$ 25.303 millions
Rockwell Medical inc 25.21%$ 25.210 millions
Intelligent Bio Solutions Inc 25.19%$ 25.188 millions
The Oncology Institute Inc 24.31%$ 24.313 millions
Vanda Pharmaceuticals Inc 24.10%$ 24.098 millions


About Anteris Technologies Global Revenue Growth Rates (AVR), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Anteris Technologies Global Corp (CIK 2011514).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001140361-26-043027
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Anteris Technologies Global Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.